ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 221 filers reported holding ALKERMES PLC in Q3 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,284,824 | +247.9% | 367,184 | +288.7% | 0.02% | +250.0% |
Q2 2023 | $2,956,629 | -22.2% | 94,461 | -29.9% | 0.01% | -25.0% |
Q1 2023 | $3,799,420 | -25.4% | 134,779 | -30.9% | 0.01% | -33.3% |
Q4 2022 | $5,093,756 | +25.5% | 194,939 | +7.3% | 0.01% | +20.0% |
Q3 2022 | $4,058,000 | +32.8% | 181,748 | +77.2% | 0.01% | +42.9% |
Q2 2022 | $3,056,000 | +15.3% | 102,578 | +1.9% | 0.01% | +40.0% |
Q1 2022 | $2,650,000 | -19.2% | 100,704 | -28.6% | 0.01% | -16.7% |
Q4 2021 | $3,280,000 | -3.6% | 141,010 | +27.8% | 0.01% | 0.0% |
Q3 2021 | $3,404,000 | -0.6% | 110,371 | -21.0% | 0.01% | 0.0% |
Q2 2021 | $3,424,000 | +119.9% | 139,623 | +67.5% | 0.01% | +100.0% |
Q1 2021 | $1,557,000 | -6.3% | 83,341 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $1,662,000 | -81.6% | 83,611 | -84.9% | 0.00% | -80.0% |
Q3 2020 | $9,033,000 | -69.4% | 553,464 | -63.7% | 0.02% | -68.8% |
Q2 2020 | $29,512,000 | -1.2% | 1,526,723 | -26.3% | 0.05% | -4.0% |
Q1 2020 | $29,878,000 | -23.5% | 2,071,950 | +7.9% | 0.05% | +13.6% |
Q4 2019 | $39,040,000 | -2.4% | 1,919,379 | -9.1% | 0.04% | -6.4% |
Q3 2019 | $39,981,000 | -24.7% | 2,110,950 | -11.2% | 0.05% | -20.3% |
Q2 2019 | $53,080,000 | +6.4% | 2,375,998 | +70.4% | 0.06% | +11.3% |
Q1 2019 | $49,872,000 | +7223.3% | 1,394,643 | +5941.9% | 0.05% | +5200.0% |
Q4 2018 | $681,000 | +62.9% | 23,083 | +134.4% | 0.00% | – |
Q3 2018 | $418,000 | -44.6% | 9,847 | -46.3% | 0.00% | -100.0% |
Q2 2018 | $755,000 | -45.1% | 18,339 | -22.8% | 0.00% | 0.0% |
Q1 2018 | $1,376,000 | -17.5% | 23,744 | -22.0% | 0.00% | -50.0% |
Q4 2017 | $1,667,000 | -20.6% | 30,460 | -26.2% | 0.00% | -33.3% |
Q3 2017 | $2,099,000 | +31.1% | 41,282 | +49.5% | 0.00% | +50.0% |
Q2 2017 | $1,601,000 | -41.8% | 27,622 | -52.8% | 0.00% | -50.0% |
Q3 2016 | $2,750,000 | -65.7% | 58,470 | -68.5% | 0.00% | -71.4% |
Q2 2016 | $8,010,000 | -85.0% | 185,338 | -88.1% | 0.01% | -85.4% |
Q1 2016 | $53,355,000 | +24.3% | 1,560,529 | +188.7% | 0.10% | +28.0% |
Q4 2015 | $42,911,000 | +358.4% | 540,577 | +238.8% | 0.08% | +294.7% |
Q3 2015 | $9,362,000 | +626.9% | 159,577 | +697.2% | 0.02% | +533.3% |
Q2 2015 | $1,288,000 | -1.6% | 20,018 | -10.4% | 0.00% | 0.0% |
Q4 2014 | $1,309,000 | – | 22,346 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
13D Management LLC | 383,584 | $10,023,050 | 5.27% |
Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |